Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.
about
Autophagy-associated immune responses and cancer immunotherapyBiomarkers for glioma immunotherapy: the next generationPathways and therapeutic targets in melanomaYou eat what you are: autophagy inhibition as a therapeutic strategy in leukemiaAutophagy in cancerPAMPs and DAMPs: signal 0s that spur autophagy and immunityTargeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancersTherapeutic Targeting of AutophagyAutophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.New frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsAutophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cellsMechanisms and applications of interleukins in cancer immunotherapy.Novel adjuvants from seaweed impede autophagy signaling in therapy-resistant residual pancreatic cancer.Yet another function of p53--the switch that determines whether radiation-induced autophagy will be cytoprotective or nonprotective: implications for autophagy inhibition as a therapeutic strategyAutophagy in pancreatic cancer pathogenesis and treatmentAutophagy is associated with chemoresistance in neuroblastoma.Autophagy is required for IL-2-mediated fibroblast growth.Localized immunotherapy via liposome-anchored Anti-CD137 + IL-2 prevents lethal toxicity and elicits local and systemic antitumor immunity.Common γ-chain cytokine signaling is required for macroautophagy induction during CD4+ T-cell activationChloroquine enhanced the anticancer capacity of VNP20009 by inhibiting autophagyThe multifaceted role of autophagy in tumor evasion from immune surveillanceAutophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.TMEM175 deficiency impairs lysosomal and mitochondrial function and increases α-synuclein aggregation.Autophagy: A novel therapeutic target for hepatocarcinoma (Review).Autophagy and transporter-based multi-drug resistance.HMGB1 in hormone-related cancer: a potential therapeutic target.Clinical relevance of autophagic therapy in cancer: Investigating the current trends, challenges, and future prospects.Glucose-independent Acetate Metabolism Promotes Melanoma Cell Survival and Tumor Growth.Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy.Biological Response Modifier in Cancer Immunotherapy.The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling.Cell-mediated autophagy promotes cancer cell survival.Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.Chloroquine anticancer activity is mediated by autophagy-independent effects on the tumor vasculature.Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain-mediated PUMA degradation.Targeting autophagy in cancer.Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents.AKAP200 promotes Notch stability by protecting it from Cbl/lysosome-mediated degradation in Drosophila melanogaster.
P2860
Q26770690-8FC36909-03B4-418A-B959-5510B281765EQ26825496-327C28CF-C17A-4C20-9976-E25EB523FE6CQ26865736-66443A66-3565-494B-923E-F022EF8AF3A2Q26998971-13A4CB96-A275-4D70-985F-3600214B61E5Q26999216-55223C75-4681-4BE3-B555-588E8B69A61EQ27004190-E2F2E918-93E4-418F-949B-720387A69D54Q27022240-4EF464BA-876C-4D72-936B-4186C7568FA7Q28078117-0FCFE006-9580-471D-9281-16109DA05F5EQ30584653-D228835B-B196-4AB2-B325-56208D90DA6CQ33709243-33E047B6-C212-4D68-9841-3A46929ACD46Q33731804-A3E41604-BEDF-4A31-975C-24F153D23E16Q33839054-690193DE-27BC-4021-A15A-ACB9379534FFQ34321166-DDFFB0EA-193B-4822-B60F-59DD2567ECCDQ34458290-34920A39-F477-45FF-9A60-2B9465CE7321Q35521264-4BAD9DBA-5C51-405A-A11E-95960EF9F4BFQ35531849-6495494B-4FCD-4746-A5E4-51468926B4FCQ36135812-838F9839-9B44-4F6B-ADFA-75C5843D5DCAQ36193465-D295E16E-DA81-4D2F-BEFE-05AEF043444DQ36585665-2839DB82-DF8F-42D4-875E-5E1DB42E74DDQ36675055-50E1595D-1E37-4AFC-92DB-535EB8786164Q36777212-3CE80680-D028-4C67-8F01-BE1FB3F94ED1Q37093323-AF593897-48B4-4E3C-99F5-64EB61E340D8Q37109549-821A3A8E-33F4-4621-84EF-2BF99FC667A9Q37299613-777D3B5E-C57A-42A8-8D3E-EDA1497E5765Q37682407-8A158353-6004-4CE3-AB06-A5D6E8B226F5Q37720015-04AFA6F8-3918-4516-8014-E8EB01B06E6DQ38202874-C4A036E4-D5FC-4D7F-AC79-6232583C4D6BQ38203471-456F69C9-DBFF-4681-8433-8399C59A6D0EQ38689955-5970DFD1-EE22-49C9-B594-8DFE1EFA8ECDQ38751146-70EC2620-EEB3-46FA-811E-D49DF4B23854Q38795278-DF94F34D-F647-411F-829E-04299343EF90Q38848213-469FA252-46C1-4004-B2C2-ED033CF1E50AQ39247356-9F755363-A0E9-4325-AA56-799CFF178E17Q39364287-EE59B17D-70B6-48C6-A542-EDEDAA49861CQ39699164-18127672-1D4E-49BF-9B93-7C175F0D9D15Q40632489-95509B08-4938-48C5-AACB-55E45FEF731EQ41842617-722ACC61-95B8-45C2-820F-4B8AED8D34CCQ41912265-A788C5F3-1998-4625-87C9-7CFE6360AEF0Q47162451-52FA7B1D-3873-48DC-90E8-A9CD6D2F19E4Q47198403-05120EA7-3F97-48FD-A29C-5E471E14E3F0
P2860
Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Inhibiting systemic autophagy ...... es long-term tumor regression.
@ast
Inhibiting systemic autophagy ...... es long-term tumor regression.
@en
type
label
Inhibiting systemic autophagy ...... es long-term tumor regression.
@ast
Inhibiting systemic autophagy ...... es long-term tumor regression.
@en
prefLabel
Inhibiting systemic autophagy ...... es long-term tumor regression.
@ast
Inhibiting systemic autophagy ...... es long-term tumor regression.
@en
P2093
P2860
P1433
P1476
Inhibiting systemic autophagy ...... tes long-term tumor regression
@en
P2093
Antonio Romo de Vivar Chavez
Bennett Van Houten
Donna Beer Stolz
Herbert J Zeh
Michael E De Vera
Michael T Lotze
Patricia Loughran
Xiaoyan Liang
P2860
P304
P356
10.1158/0008-5472.CAN-12-0320
P407
P577
2012-04-03T00:00:00Z